Erratum to: C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients

Mohamed Jalloul Nsaibia; Marc Lapointe; H. Mabrouk; Wahiba Douki; L. Gaha; Louis Pérusse; Claude Bouchard; Besma Bel Hadj Jrad; Katherine Cianflone

doi:10.1007/s11064-016-1866-4

Related publications

Article2015

C3 Polymorphism Influences Circulating Levels of C3, ASP and Lipids in Schizophrenic Patients

Mohamed Jalloul Nsaiba, Marc Lapointe, H. Mabrouk, Wahiba Douki, L. Gaha, Louis Pérusse, Claude Bouchard, Besma Bel Hadj Jrad, Katherine Cianflone

Neurochemical Research

Article1999

Longitudinal changes of plasma HVA and 5-HIAA levels in schizophrenic patients resistant to neuroleptics

Luisella Bocchio‐Chiavetto, Stefano Bignotti, G.B. Tura, Michael Maes, Rosaria Pioli, Carlo Altamura, Giorgio Racagni

Article2016

Adherence to Antipsychotic Medication in Bipolar Disorder and Schizophrenic Patients

Sainza García, Mónica Martínez‐Cengotitabengoa, Saioa López-Zurbano, Eric P. Zorrilla, Purificación López‐Mahía, Eduard Vieta, Ana González‐Pinto

Article1992

Suicide attempts of high medical seriousness in schizophrenic patients

E. Nieto, Eduard Vieta, Cristòbal Gastó, J. Vallejo, E Cirera

Article2015

Prognostic and diagnostic potential of local and circulating levels of pentraxin 3 in lung cancer patients

Maurizio Infante, Paola Allavena, Cecília Garlanda, Manuela Nebuloni, Emanuela Morenghi, Daoud Rahal, Massimo Roncalli, Silvio Cavuto, Samantha Pesce, Marta Monari, Serenella Valaperta, Alessandro Montanelli, Daniel Solomon, Edoardo Bottoni, Valentina Errico, Emanuele Voulaz, Manuela Bossi, Giuseppe Chiesa, Eliseo Passera, Alberto Mantovani, Marco Alloisio